Paul Battista is an Author at Lifeboat Foundation. He focuses on a diverse range of themes including science, natural sciences, medicine and healthcare, particularly in areas such as aging and longevity, neuroscience, and wellness programs. Battista's extensive work, comprising 4,957 posts, reflects his commitment to exploring the intersections of health, technology, and alternative medicine.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Paul Battista's coverage predominantly focuses on scientific themes, specifically biomedical research, gene editing, quantum physics, longevity, and CRISPR technology. He frequently cites data and press releases in his articles.
To effectively engage with Paul, it is important to provide him with well-researched data-backed insights within the specific scientific fields he covers. Researchers or professionals involved in groundbreaking studies related to these topics would likely capture his interest. Additionally, individuals associated with organizations or companies making significant advancements in biomedicine and quantum physics may also be valuable contacts for Paul.
Given that there is no specified geographic focus for Paul's coverage area, experts from any location who are at the forefront of developments in these scientific domains could be relevant sources for him.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Plus cryptography & cryonics, information theoretic death, and obstacles to acceptance of biostasis
Most known for its role in movement, the cerebellum could compensate for flagging mental functions elsewhere in the brain.
By: Paul Battista
A preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published today in Cell , details a connection between
By: Paul Battista
What if aging isn't just biology…but also psychology — and your brain is quietly shaping how fast you age every day?
By: Paul Battista
She says she reversed 20 years of biological aging by testing gene therapy on her own body before anyone else.
The first human trial of epigenetic reprogramming is underway. Scientists are testing whether three genes can make old cells behave like
The first human trial of this age-reversal technology is officially underway.
By: Paul Battista
The biology behind Project Hail Mary's coma pods is one of the most important untapped pathways in longevity medicine
Today, more people are living past 100 than ever before — even though the maximum human lifespan hasn't moved past 115 years. But is that about to change?
Today's age-reversal therapies can cost up to $2 million per patient.
